ongoing trials of ruxolitinib, momelotinib and imetelstat in myelofibrosis
Published 7 years ago • 832 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
5:12
ongoing clinical trials of ruxolitinib-based combinations in myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:38
pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
-
3:35
new phase iii trial of imetelstat versus bat in jak inhibitor-refractory myelofibrosis
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
3:19
first-line treatment selection in myelofibrosis
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
4:10
the management of prefibrotic myelofibrosis
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
1:44
an update on imetelstat in r/r myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
1:34
pelabresib in myelofibrosis: the manifest trials
-
2:39
a phase ii trial of ruxolitinib and azacitidine combination therapy in patients with myelofibrosis
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
4:25
update on momelotinib for myelofibrosis
-
2:16
long-term safety of momelotinib for myelofibrosis
-
1:52
the role of ruxolitinib in the treatment of early-stage myelofibrosis
-
4:39
imetelstat shows promise in advanced myelofibrosis